Press Release
MDxHealth Shareholder Transparency Notification
IRVINE, CA, and HERSTAL, BELGIUM, November 26, 2014 - 8:00 AM CET - MDxHealth SA (Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, announced today that it received the following notification of significant shareholdings, in accordance with the Belgian Act of May 2, 2007 on the disclosure of significant shareholdings in issuers of which the shares are admitted to trading on a regulated market.
Shareholdings after actively crossing the transparency threshold:
Edmond de Rothschild Investment Partners S.A.S.informed MDxHealth on November 24, 2014 that, as of November 18, 2014, its participation in MDxHealth fell below the threshold of 3% of the outstanding shares. Edmond de Rothschild Investment Partners now owns 1,001,288 shares, i.e. 2.66 % of the outstanding shares of MDxHealth. Edmond de Rothschild Investment Partners is part of the group Edmond de Rothschild. For further information, reference is made to the information published on MDxHealth's website (http://www.mdxhealth.com/investors/shareholder-information).